| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2012.42.9936 |
| P698 | PubMed publication ID | 23269991 |
| P50 | author | Rongping Guo | Q57613357 |
| P2093 | author name string | Li Xu | |
| Yao-Jun Zhang | |||
| Min-Shan Chen | |||
| Xiao-Jun Lin | |||
| Ya-Qi Zhang | |||
| Wan Yee Lau | |||
| Zhen-Wei Peng | |||
| Hui-Hong Liang | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 426-432 | |
| P577 | publication date | 2012-12-26 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial | |
| P478 | volume | 31 |
| Q49985544 | 131I-Labeled Copper Sulfide-Loaded Microspheres to Treat Hepatic Tumors via Hepatic Artery Embolization. |
| Q64272871 | 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma |
| Q91599660 | 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma |
| Q28067517 | A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma |
| Q97524094 | Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis |
| Q92249512 | Advanced intrahepatic cholangiocarcinoma treated using anlotinib and microwave ablation: A case report |
| Q41430971 | BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A. |
| Q36596607 | Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma |
| Q89953523 | Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation |
| Q37327741 | Chemolipiodolization with or without embolization in transcatheter arterial chemoembolization combined with radiofrequency ablation for hepatocellular carcinoma-propensity score matching analysis |
| Q26864261 | Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis |
| Q34130169 | Combination of percutaneous radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: observation of clinical effects |
| Q35159031 | Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis |
| Q26766127 | Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art |
| Q52619956 | Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study. |
| Q49645949 | Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery |
| Q48327209 | Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm |
| Q52656864 | Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study. |
| Q57812099 | Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis |
| Q53059127 | Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma. |
| Q37716505 | Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparison |
| Q47104262 | Comparison of Combined Transcatheter Arterial Chemoembolization and CT-guided Radiofrequency Ablation with Surgical Resection in Patients with Hepatocellular Carcinoma within the Up-to-seven Criteria: A Multicenter Case-matched Study |
| Q36345251 | Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation |
| Q55003707 | Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas. |
| Q39106320 | Computational simulation of the predicted dosimetric impact of adjuvant yttrium-90 PET/CT-guided percutaneous ablation following radioembolization |
| Q89623916 | Controversies in the management of hepatocellular carcinoma |
| Q39043108 | Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study |
| Q47566919 | Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma. |
| Q50317485 | Cryoablation with drug-loaded bead embolization in the treatment of unresectable hepatocellular carcinoma: safety and efficacy analysis |
| Q38640531 | Curative therapies for hepatocellular carcinoma: an update and perspectives |
| Q90473800 | Curative-Intent Therapies in Localized Hepatocellular Carcinoma |
| Q38410816 | Current management of hepatocellular carcinoma: an Eastern perspective |
| Q28551586 | Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma |
| Q38408866 | Diagnosis and treatment of hepatocellular carcinoma: An update |
| Q26999043 | Diagnostic and therapeutic management of hepatocellular carcinoma |
| Q26740315 | Diagnostics and Treatment of Hepatocellular Carcinoma in 2016: Standards and Developments |
| Q64109256 | Dissecting the roles of thymoquinone on the prevention and the treatment of hepatocellular carcinoma: an overview on the current state of knowledge |
| Q99238790 | Drug-eluting beads transarterial chemoembolization sequentially combined with radiofrequency ablation in the treatment of untreated and recurrent hepatocellular carcinoma |
| Q40121491 | Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial. |
| Q50458927 | Effectiveness of combined (131)I-chTNT and radiofrequency ablation therapy in treating advanced hepatocellular carcinoma. |
| Q35900872 | Efficacy and Safety of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinomas Compared with Radiofrequency Ablation Alone: A Time-to-Event Meta-Analysis |
| Q35743221 | Efficacy and safety of radiofrequency ablation and transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: A meta-analysis |
| Q37613344 | Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion im |
| Q90435356 | Evaluation of the Heat Sink Effect After Transarterial Embolization When Performed in Combination with Thermal Ablation of the Liver in a Rabbit Model |
| Q98195780 | Feasibility of High-Intensity Focused Ultrasound for Hepatocellular Carcinoma after Stereotactic Body Radiation Therapy: Initial Experience |
| Q57494813 | Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition) |
| Q89967093 | Hepatic Resection Is Associated With Improved Long-Term Survival Compared to Radio-Frequency Ablation in Patients With Multifocal Hepatocellular Carcinoma |
| Q64091614 | Hepatic resection percutaneous radiofrequency ablation of hepatocellular carcinoma abutting right diaphragm |
| Q33841219 | Hepatocellular Carcinoma in Children and Adolescents: Clinical Characteristics and Treatment |
| Q38163597 | Hepatocellular carcinoma and cholangiocarcinoma: an update |
| Q64901948 | Hepatocellular carcinoma: asphyxiate and then cook. |
| Q35112053 | Hepatocellular carcinoma: clinical frontiers and perspectives |
| Q33881131 | Hepatocellular carcinoma: early-stage management challenges |
| Q35631295 | Hong Kong consensus recommendations on the management of hepatocellular carcinoma |
| Q26770565 | Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective |
| Q38324277 | Image-guided ablation of primary liver and renal tumours |
| Q86095472 | Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update |
| Q34680997 | Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update |
| Q38922919 | Imaging review of hepatocellular carcinoma after thermal ablation: The good, the bad, and the ugly |
| Q58559604 | Interventional Oncology: Treatment of primary liver tumors and liver metastases. Part II: non-nuclear techniques |
| Q98290413 | Intra-procedural real-time ultrasound fusion imaging improves the therapeutic effect and safety of liver tumor ablation in difficult cases |
| Q35921719 | Intraductal Radiofrequency Ablation Followed by Locoregional Tumor Treatments for Treating Occluded Biliary Stents in Non-Resectable Malignant Biliary Obstruction: A Single-Institution Experience |
| Q50027486 | Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma. |
| Q35370564 | Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives |
| Q35903794 | Liver cancer: Approaching a personalized care |
| Q64101477 | Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma |
| Q46800739 | Liver-directed therapy for hepatocellular carcinoma. |
| Q96584579 | Local and Regional Therapies for Hepatocellular Carcinoma |
| Q35152457 | Locally ablative therapies for primary and metastatic liver cancer. |
| Q90136078 | Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions |
| Q57052950 | Long-term follow-up of unresectable medium-large hepatocellular carcinoma nodules treated with radiofrequency ablation using a using multiple-electrode switching system |
| Q33643009 | Managing the changing burden of cancer in Asia |
| Q37251634 | Microwave ablation of hepatocellular carcinoma as first-line treatment: long term outcomes and prognostic factors in 221 patients |
| Q34974386 | Minimally invasive local therapies for liver cancer |
| Q28087569 | Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine |
| Q55361374 | Multi-Operational Selective Computer-Assisted Targeting of hepatocellular carcinoma-Evaluation of a novel approach for navigated tumor ablation. |
| Q27314889 | Novel Hydrogel Material as a Potential Embolic Agent in Embolization Treatments |
| Q37542835 | Novel implications in the treatment of hepatocellular carcinoma |
| Q91583210 | Overview of Ablative Therapy for Hepatocellular Carcinoma |
| Q38132281 | Patient selection for liver transplantation |
| Q47440581 | Patterns and challenges of treatment sequencing in patients with hepatocellular carcinoma: Experience from a German referral center |
| Q35668720 | Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. |
| Q35057013 | Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why? |
| Q64084332 | Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram |
| Q36668228 | Prospective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma |
| Q90472233 | Radiofrequency Ablation Combined With Transarterial Chemoembolization for Specially Located Small Hepatocellular Carcinoma |
| Q55378692 | Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis. |
| Q52929135 | Radiofrequency ablation combined with transarterial chemoembolization versus hepatectomy for patients with hepatocellular carcinoma within Milan criteria: a retrospective case-control study. |
| Q38128370 | Radiofrequency ablation for hepatocellular carcinoma |
| Q50785082 | Radiofrequency ablation versus open hepatic resection for elderly patients (> 65 years) with very early or early hepatocellular carcinoma. |
| Q36924891 | Radiofrequency and microwave ablation in combination with transarterial chemoembolization induce equivalent histopathologic coagulation necrosis in hepatocellular carcinoma patients bridged to liver transplantation |
| Q38845532 | Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma |
| Q38845317 | Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study |
| Q40968769 | Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria |
| Q37595643 | Role of embolization in the treatment of renal masses |
| Q48111688 | Role of interventional radiology in managing pediatric liver tumors : Part 2: percutaneous interventions. |
| Q34207863 | Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma |
| Q36414519 | Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma after a complete response |
| Q92454698 | Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study |
| Q37601179 | Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience |
| Q90296549 | Stereotactic Radiofrequency Ablation of Hepatocellular Carcinoma: a Histopathological Study in Explanted Livers |
| Q58806078 | Stereotactic body radiation therapy following transarterial chemoembolization for unresectable hepatocellular carcinoma |
| Q47098597 | Surrogate endpoint for overall survival in assessment of adjuvant therapies after curative treatment for hepatocellular carcinoma: a re-analysis of meta-analyses of individual patients' data |
| Q34905429 | Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological response |
| Q36544919 | TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling |
| Q38233028 | Technical and practical considerations for device selection in locoregional ablative therapy |
| Q92291497 | Temperature mapping of exothermic in situ chemistry: imaging of thermoembolization via MR |
| Q90171775 | The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma |
| Q38970852 | The Effectiveness of Multiple Electrode Radiofrequency Ablation in Patients with Hepatocellular Carcinoma with Lesions More than 3 cm in Size and Barcelona Clinic Liver Cancer Stage A to B2. |
| Q35106641 | The efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization for primary hepatocellular carcinoma in a cohort of 487 patients |
| Q38181127 | The role of bridging therapy in hepatocellular carcinoma |
| Q27016138 | Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. |
| Q38201633 | Transarterial chemoembolization and bland embolization for hepatocellular carcinoma |
| Q38923548 | Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy |
| Q59795920 | Transarterial chemoembolization with radiofrequency ablation versus hepatectomy in hepatocellular carcinoma beyond the Milan criteria: a retrospective study |
| Q40334557 | Transcatheter arterial chemoembolization as an examination method for hepatocellular carcinoma undetected by B-mode ultrasound, computed tomography and digital subtratcion angiography: A case report |
| Q36121249 | Transcatheter arterial chemoembolization combined with CT-guided percutaneous thermal ablation versus hepatectomy in the treatment of hepatocellular carcinoma |
| Q34636766 | Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma |
| Q27003849 | Transcatheter embolization therapy in liver cancer: an update of clinical evidences |
| Q38590448 | Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion. |
| Q38096477 | Treatment of hepatocellular carcinoma: present and future |
| Q38236876 | Treatment of intermediate-stage hepatocellular carcinoma |
| Q89932046 | Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation |
| Q38146836 | Treatment outcomes of transcatheter arterial chemoembolization combined with local ablative therapy versus monotherapy in hepatocellular carcinoma: a meta-analysis |
| Q57477839 | Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation |
| Q53646166 | Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal? |
| Q41618156 | Utility of percutaneous radiofrequency ablation alone or combined with transarterial chemoembolization for early hepatocellular carcinoma |
| Q47140233 | What is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? a systematic review and network meta-analysis |
Search more.